Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients

Published:2016-05-23 Issue:9 Volume:55 Page:1673-1680
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Nagaraju Kanneboyina,Ghimbovschi Svetlana,Rayavarapu Sree,Phadke Aditi,Rider Lisa G.,Hoffman Eric P.,Miller Frederick W.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/55/9/1673/18097898/kew213.pdf

Reference20 articles.

1. Deciphering the Clinical Presentations, Pathogenesis, and Treatment of the Idiopathic Inflammatory Myopathies

2. International consensus on preliminary definitions of improvement in adult and juvenile myositis

3. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial

4. Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis;Aggarwal;Arthritis Rheum,2013

5. Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review;Children;2024-08-27

2. A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients;Rheumatology;2022-12-08

3. The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease;The Lancet Rheumatology;2022-01

4. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies;Arthritis Research & Therapy;2020-04-06

5. Management Considerations: Juvenile Dermatomyositis;Managing Myositis;2019-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3